What is Zacks Research’s Estimate for Nukkleus Q3 Earnings?

Nukkleus Inc. (NASDAQ:DFNS) – Stock analysts at Zacks Research issued their Q3 2026 earnings per share estimates for shares of Nukkleus in a research note issued to investors on Monday, September 14th. Zacks Research analyst T. Kerr expects that the company will post earnings per share of ($2.36) for the quarter. The consensus estimate for Nukkleus’ current full-year earnings is ($3.90) per share. Zacks Research also issued estimates for Nukkleus’ Q4 2026 earnings at ($1.80) EPS, FY2027 earnings at ($1.70) EPS, FY2028 earnings at $0.46 EPS, FY2029 earnings at $1.13 EPS and FY2030 earnings at $1.84 EPS.

Several other equities research analysts have also issued reports on DFNS. Wall Street Zen lowered shares of Nukkleus from a “sell” rating to a “strong sell” rating in a research report on Saturday, September 5th. Weiss Ratings cut shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. Finally, Noble Financial upgraded Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Nukkleus presently has a consensus rating of “Moderate Buy”.

Nukkleus Trading Down 7.2%

NASDAQ DFNS opened at $7.68 on Thursday. The firm has a market capitalization of $12.75 million, a price-to-earnings ratio of -0.02 and a beta of -5.88. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.11 and a current ratio of 0.14. Nukkleus has a one year low of $3.70 and a one year high of $1,948.75. The company’s 50 day moving average price is $20.64 and its 200 day moving average price is $57.55.

Nukkleus (NASDAQ:DFNS) last issued its earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The firm had revenue of $4.00 million during the quarter, compared to analyst estimates of $4.50 million.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.